200 related articles for article (PubMed ID: 22003437)
1. Regulation and function of the TAZ transcription co-activator.
Liu C; Huang W; Lei Q
Int J Biochem Mol Biol; 2011; 2(3):247-56. PubMed ID: 22003437
[TBL] [Abstract][Full Text] [Related]
2. TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma.
de Cristofaro T; Di Palma T; Ferraro A; Corrado A; Lucci V; Franco R; Fusco A; Zannini M
Eur J Cancer; 2011 Apr; 47(6):926-33. PubMed ID: 21131195
[TBL] [Abstract][Full Text] [Related]
3. TAZ Controls
Tiffon C; Giraud J; Molina-Castro SE; Peru S; Seeneevassen L; Sifré E; Staedel C; Bessède E; Dubus P; Mégraud F; Lehours P; Martin OCB; Varon C
Cells; 2020 Jun; 9(6):. PubMed ID: 32545795
[No Abstract] [Full Text] [Related]
4. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
Xiao H; Jiang N; Zhou B; Liu Q; Du C
Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TAZ in cancer.
Zhou X; Lei QY
Protein Cell; 2016 Aug; 7(8):548-61. PubMed ID: 27412635
[TBL] [Abstract][Full Text] [Related]
6. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
7. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
Liu CY; Lv X; Li T; Xu Y; Zhou X; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2011 Feb; 286(7):5558-66. PubMed ID: 21189257
[TBL] [Abstract][Full Text] [Related]
8. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
9. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
10. A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma.
Shen S; Huang K; Wu Y; Ma Y; Wang J; Qin F; Ma J
Cancer Lett; 2017 Oct; 407():32-44. PubMed ID: 28823959
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.
Huang W; Lv X; Liu C; Zha Z; Zhang H; Jiang Y; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2012 Jul; 287(31):26245-53. PubMed ID: 22692215
[TBL] [Abstract][Full Text] [Related]
13. TAZ Induction Directs Differentiation of Thyroid Follicular Cells from Human Embryonic Stem Cells.
Ma R; Morshed SA; Latif R; Davies TF
Thyroid; 2017 Feb; 27(2):292-299. PubMed ID: 27829313
[TBL] [Abstract][Full Text] [Related]
14. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
15. Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes.
Kuroda M; Wada H; Kimura Y; Ueda K; Kioka N
J Cell Sci; 2017 Mar; 130(5):989-1002. PubMed ID: 28115535
[TBL] [Abstract][Full Text] [Related]
16. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.
Chan SW; Lim CJ; Guo K; Ng CP; Lee I; Hunziker W; Zeng Q; Hong W
Cancer Res; 2008 Apr; 68(8):2592-8. PubMed ID: 18413727
[TBL] [Abstract][Full Text] [Related]
17. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
[TBL] [Abstract][Full Text] [Related]
18. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
19. CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity.
Zhang L; Chen X; Stauffer S; Yang S; Chen Y; Dong J
Oncotarget; 2015 Oct; 6(31):31399-412. PubMed ID: 26375055
[TBL] [Abstract][Full Text] [Related]
20. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
